FDA’s Electronic Records and Electronic Signatures Rule (“Part 11”) defines the requirements for submitting documentation to FDA in electronic form as well as criteria for use of electronic signatures. These regulations – which affect the creation, maintenance, transmission, storage, modification, and submission of electronic records -- have added new challenges to the regulated life science industries. To verify conclusions you make from test data, FDA wants to be able to use the same tools to evaluate data that you did. The FDA also requires that you can account for every detail as to how you arrived at your results. Key to such data evaluation and manipulation is a means to control the metadata – the data that software uses to render your data into meaningful reports.
FCS Express with tools to help customers meet CFR Part 11 compliance. Designed to maintain both the machine-readable metadata and human-readable reports, FCS has the following features to enhance your Part 11 compliance program:
Our 21 CFR Part 11 Compliance Matrix highlights all of the Part 11 regulations and how FCS Express facilitates your compliance with them.